PUBBLICAZIONI GISCAD

pagina 9

· 

Intensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: report from the Italian Group for the Study Of Digestive Tract Cancer (GISCAD)

Cascinu S, Labianca R, Graziano F, Pancera G, Barni S, Frontini L, Luporini G, Celerino R, Catalano G.

Br J Cancer 1998; Aug 78 (3): 390-3

· 

GIVIO - SITAC-01. A randomized trial of Adjuvant 5-fluorouracil and folinic acid administered to patients with colon carcinoma - Long term results and evaluation of the indicators of health-related Quality of Life

Zaniboni A, Labianca R, Marsoni S, Torri V, Mosconi P, Grilli R, Apolone G, Cifani S, Tinazzi A for the SITAC-01 Investigators.

Cancer 1998; Jun 82 (11): 3313-19

· 

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epic-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report form the Italian Group for the Study of Digestive Tract Cancer.

Cascinu S, Labianca R, Alessandrini P, Marcellino M, Silva RR, Pancera G, Testa E, Martignoni G, Barni S, Frontini L, Zaniboni A, Leporini G, Celerino R, Catalano G.

JCO 1997; Nov 15(11): 3313-19

· 

Evaluation on factors influencing 5-fluorouracil-induced diarrhea in colorectal cancer patients. An Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Cascinu S, Barni S, Labianca R, Del Ferro E, Occhi MB, Ligi M, Pessi MA, Cazzaniga M, Zamparelli G, Ardozzoia A, Ugolini G, Ghiandoni G, Luporini G,

Catalano G.

Support CareCancer 1997; Jul 5(4): 314-7

· 

High-versus low-dose levo-luecovorin as a modulator of 5-fluorouracil in advanced colorectal cancer: a GISCAD phase III study. Italian Group for the Study of Digestive Tract Cancer

Labianca R, Cascinu S, Frontini L, Barni S, Fiorentini G, Comella G, Zaniboni A, Gottardi O, Arnoldi E, Oliani C, Duro M, Pavanato G, Martignoni G, Raina A, Piazza E, Dellavalle G, Valsecchu R, Pancera G, Luporini G.

Anno Oncol. 1997; Feb 8(2): 169-74

· 

Preliminary report of an ongoing trial comparing surgery alone versus surgery and chemotherapy in operable gastric cancer.

J Chemother, 1996; 8 (suppl 4): 104-06

Di Costanzo F, Gasperoni S, Labianca R, Sdrobolini A, Zamparelli G, Angiona S, Bartolucci R, Rossetti R.

FONDAZIONE
GISCAD

GRUPPO ITALIANO PER LO STUDIO DEI 

CARCINOMI DELL'APPARATO DIGERENTE

SEDE

Via Gattinoni, 4

20010 Vanzago (MI)

CONTATTI

Tel. 02 84968409

ufficio.operativo@giscad.it

© 2018 Fondazione GISCAD - P.IVA 05396970963